Neurocrine Biosciences (NBIX) Misses Q1 EPS by 5c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $142.25 -1.19%
EPS Growth %: -12.4%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -12.4%
Financial Fact:
Total revenues: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of $0.49, $0.05 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $236.6 million versus the consensus estimate of $252.55 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
- Progress Software completes $400M acquisition of Domo's data platform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
